Table 3.

CR Model

Factor3-150Effect on Survival P Value3-151
Age Unfavorable  <.001  
Platelets  CR rate improves as pretreatment platelet count increases from less than 5,000 to approximately 210,000, then worsens with further increase in platelets <.001  
PE  Favorable  .002  
PS 3, 4  Unfavorable <.001  
−5/−7  Unfavorable  <.001  
Other poor  cytogenetics  Unfavorable  .056  
G-CSF ± ATRA Favorable  .018 
Factor3-150Effect on Survival P Value3-151
Age Unfavorable  <.001  
Platelets  CR rate improves as pretreatment platelet count increases from less than 5,000 to approximately 210,000, then worsens with further increase in platelets <.001  
PE  Favorable  .002  
PS 3, 4  Unfavorable <.001  
−5/−7  Unfavorable  <.001  
Other poor  cytogenetics  Unfavorable  .056  
G-CSF ± ATRA Favorable  .018 
F3-150

See Table 2 for details.

F3-151

Nonsignificant factors include RAEB or RAEB-t (rather than AML) (P = .68), one previous course of outside therapy (P = .58), ATRA ± G-CSF (P = .35).

View Large
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal